Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
56.8M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+11.4M
-
Total reported value, excl. options
-
$80.4M
-
Value change
-
+$34.2M
-
Put/Call ratio
-
1.1
-
Number of buys
-
54
-
Number of sells
-
-16
-
Price
-
$2.99
Significant Holders of Verastem, Inc. - Common Stock, $0.0001 par value (VSTM) as of Q3 2024
89 filings reported holding VSTM - Verastem, Inc. - Common Stock, $0.0001 par value as of Q3 2024.
Verastem, Inc. - Common Stock, $0.0001 par value (VSTM) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 56.8M outstanding shares and own 46.78% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (3.73M shares), ORBIMED ADVISORS LLC (2.86M shares), Soleus Capital Management, L.P. (2.83M shares), BlackRock, Inc. (2.23M shares), VANGUARD GROUP INC (1.93M shares), Alyeska Investment Group, L.P. (1.86M shares), BVF INC/IL (1.69M shares), Vivo Capital, LLC (1.54M shares), ARMISTICE CAPITAL, LLC (1.36M shares), and Stonepine Capital Management, LLC (1.31M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.